Lt3001 Podcast
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Lt3001 Podcast
-
Narrated by:
-
By:
About this listen
Patients with AIS and disabling symptoms often have limited treatment options, particularly when reperfusion therapies are not feasible. LT3001 (Odatroltide), a novel molecule that enhances endogenous fibrinolysis and scavenges free radicals, was evaluated in two Phase 2 trials with distinct selection strategies
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.